Discover how Spinally founder and CEO Pawel Soluch is pioneering a new intrathecal neural interface, FuturaLead™, designed to enable safer, more precise recording and stimulation directly from the spinal cord. In this interview, he shares insights on the future of spinal neurotechnology, the challenges of translating science into surgical reality, and what’s next for restoring function through minimally invasive neuromodulation.

Omari Bouknight, CEO of Resonant Link Medical, shares how his team is building the wireless backbone for the next generation of implantable devices — from neurostimulation and BCI to cardiac care. In this exclusive interview, he discusses the company’s journey, the Orion platform’s core innovations, and what it takes to bring high-performance power and data transfer into the body.

From lab to clinic, NeuroBionics is redefining neuromodulation with flexible, vascular‑based neural interfaces. In this interview, co‑founder Nicolette Driscoll shares her journey, the technical breakthroughs behind their evStim device, and how they’re pushing neurotechnology forward.

Sam Hosovsky, CEO of uCat, shares his journey into neurotechnology and how his company is transforming brain-computer interface (BCI) development through VR-based training and avatar embodiment. Discover how uCat is helping redefine clinical adoption of BCIs.